Zhu DH - Search Results

1

TRAF4 Promotes Fibroblast Proliferation in Keloids by Destabilizing p53 via Interacting with the Deubiquitinase USP10.

Deng CC, Zhu DH, Chen YJ, Huang TY, Peng Y, Liu SY, Lu P, Xue YH, Xu YP, Yang B, Rong Z. Deng CC, et al. Among authors: zhu dh. J Invest Dermatol. 2019 Sep;139(9):1925-1935.e5. doi: 10.1016/j.jid.2019.03.1136. Epub 2019 Mar 30. J Invest Dermatol. 2019. PMID: 30940456 Free article.

2

Racial/ethnic disparities in penile squamous cell carcinoma incidences, clinical characteristics, and outcomes: A population-based study, 2004-2016.

Huang T, Xu Y, Hu G, Zhu D, Xiao S, He R. Huang T, et al. Urol Oncol. 2020 Aug;38(8):688.e11-688.e19. doi: 10.1016/j.urolonc.2020.03.003. Epub 2020 Apr 25. Urol Oncol. 2020. PMID: 32340796

3

Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases.

Deng CC, Hu YF, Zhu DH, Cheng Q, Gu JJ, Feng QL, Zhang LX, Xu YP, Wang D, Rong Z, Yang B. Deng CC, et al. Among authors: zhu dh. Nat Commun. 2021 Jun 17;12(1):3709. doi: 10.1038/s41467-021-24110-y. Nat Commun. 2021. PMID: 34140509 Free PMC article.

4

Keratoacanthoma centrifugum marginatum: An unusual case.

Qi S, Huang T, Zhu D, Pan H, He R. Qi S, et al. Photodiagnosis Photodyn Ther. 2021 Dec;36:102468. doi: 10.1016/j.pdpdt.2021.102468. Epub 2021 Jul 29. Photodiagnosis Photodyn Ther. 2021. PMID: 34333144

5

Chemical peeling with 35% glycolic acid for the treatment of disseminated facial verruca plana: A randomized, split-face, evaluator-blinded trial.

Liu Z, Ai J, Zhu Z, Huang L, Yi Z, Wu L, Xu Y, Zhu D, Li H, Yan Y, Zhang L, Zhong X, Yang B. Liu Z, et al. Dermatol Ther. 2022 Aug;35(8):e15594. doi: 10.1111/dth.15594. Epub 2022 Jun 15. Dermatol Ther. 2022. PMID: 35617452 Clinical Trial.

6

Case report: B7-H3 CAR-T therapy partially controls tumor growth in a basal cell carcinoma patient.

Hu G, Li G, Wen W, Ding W, Zhou Z, Zheng Y, Huang T, Ren J, Chen R, Zhu D, He R, Liang Y, Luo M. Hu G, et al. Front Oncol. 2022 Aug 17;12:956593. doi: 10.3389/fonc.2022.956593. eCollection 2022. Front Oncol. 2022. PMID: 36059640 Free PMC article.

7

Risk single-nucleotide polymorphism-mediated enhancer-promoter interaction drives keloids through long noncoding RNA down expressed in keloids.

Deng CC, Zhang LX, Xu XY, Zhu DH, Cheng Q, Ma S, Rong Z, Yang B. Deng CC, et al. Among authors: zhu dh. Br J Dermatol. 2023 Jan 23;188(1):84-93. doi: 10.1093/bjd/ljac025. Br J Dermatol. 2023. PMID: 36689521

8

Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids.

Gu JJ, Deng CC, Feng QL, Liu J, Zhu DH, Cheng Q, Rong Z, Yang B. Gu JJ, et al. Among authors: zhu dh. J Invest Dermatol. 2023 Jul;143(7):1208-1219.e6. doi: 10.1016/j.jid.2023.01.008. Epub 2023 Jan 28. J Invest Dermatol. 2023. PMID: 36716919 Free article.

9

An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid.

Chen JY, Feng QL, Pan HH, Zhu DH, He RL, Deng CC, Yang B. Chen JY, et al. Among authors: zhu dh. Dermatology. 2023;239(5):818-827. doi: 10.1159/000532064. Epub 2023 Aug 29. Dermatology. 2023. PMID: 37643592 Clinical Trial.

10

PURPL represses autophagic cell death to promote cutaneous melanoma by modulating ULK1 phosphorylation.

Han S, Li X, Wang K, Zhu D, Meng B, Liu J, Liang X, Jin Y, Liu X, Wen Q, Zhou L. Han S, et al. Cell Death Dis. 2021 Nov 10;12(11):1070. doi: 10.1038/s41419-021-04362-8. Cell Death Dis. 2021. PMID: 34759263 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters